President Trump has been making policy decisions that directly impact health care. Most of them are not good for patients.
With the FDA receiving the vast majority of its funding to regulate drugs from that very industry, that’s a dangerous conflict of interest that puts everyone’s health at risk.
Pharmaceutical companies are getting bolder with pushing off-label drug use to doctors, but will an upcoming meeting embolden the FDA to get tougher?
The next National Prescription Drug Take-Back Day is Oct. 19. Find out why it is important to get rid of unused drugs and how to dispose of them properly.
The FDA has new powers to regulate e-cigarettes. The agency should use them to restrict advertising to teens and ban flavored vaping liquid that appeals directly to young people.
The FDA’s approval this week of a new drug with weak trial data for muscular dystrophy was based on public pressure rather than sound science.